GENTEX CORP
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.5B | $2.3B | $2.3B | $1.9B | $1.7B |
| Cost of revenue | $1.7B | $1.5B | $1.5B | $1.3B | $1.1B |
| Gross profit | $866.7M | $771.1M | $762.6M | $609.8M | $619.7M |
| Selling, general & administrative | $177.9M | $121.0M | $112.5M | $106.5M | $92.2M |
| Research and development | $203.3M | $181.5M | $154.4M | $133.3M | $117.8M |
| Operating expenses | $392.8M | $311.4M | $266.9M | $239.8M | $209.9M |
| Operating income | $473.9M | $459.7M | $495.7M | $370.0M | $409.8M |
| Pretax income | $461.1M | $472.2M | $505.0M | $369.7M | $416.4M |
| Income tax expense | $76.4M | $67.7M | $76.6M | $51.0M | $55.6M |
| Net income | $384.8M | $404.5M | $428.4M | $318.8M | $360.8M |
| Balance Sheet | |||||
| Cash and equivalents | $145.6M | $233.3M | $226.4M | $214.8M | $262.3M |
| Current assets | $1.1B | $1.0B | $997.7M | $948.7M | $873.0M |
| Total assets | $2.9B | $2.8B | $2.6B | $2.3B | $2.1B |
| Current liabilities | $387.5M | $252.7M | $271.6M | $250.6M | $181.7M |
| Total liabilities | $437.7M | $288.7M | $298.9M | $261.4M | $193.4M |
| Stockholders' equity | $2.5B | $2.5B | $2.3B | $2.1B | $1.9B |
| Cash Flow Statement | |||||
| Cash from operations | $587.1M | $498.2M | $537.2M | $338.2M | $362.2M |
| Depreciation and amortization | $104.0M | $94.7M | $93.3M | $96.6M | $99.1M |
| Stock-based compensation | $36.6M | $39.5M | $39.2M | $30.2M | $27.4M |
| Capital expenditure | $129.1M | $144.7M | $183.7M | $146.4M | $68.8M |
| Free cash flow | $458.0M | $353.5M | $353.6M | $191.8M | $293.3M |
| Dividends paid | $106.9M | $110.4M | $112.2M | $113.1M | $115.3M |
| Share repurchases | $315.5M | $206.1M | $147.4M | $112.5M | $324.6M |
| Impairments | $0 | $8.9M | $0 | $0 | $0 |
Shares outstanding 213.0M · Free float 96.6%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.